POEM is Not Yet the Universal Gold Standard for Achalasia—It is a Treatment Option Comparable to Laparoscopic Heller Myotomy
POEM should be considered a treatment option comparable to laparoscopic Heller myotomy (LHM) for achalasia, not a universal gold standard, though it may be preferred for type III (spastic) achalasia. 1
Current Status According to Guidelines
The most recent 2024 AGA Clinical Practice Update 2 and the 2017 AGA expert review 1 position POEM as:
- Comparable to LHM for all achalasia subtypes when expertise is available
- Preferred primary therapy for type III achalasia specifically, where the longer myotomy possible with POEM offers advantages
- A procedure requiring 20-40 cases to achieve competence, limiting its availability to high-volume centers
The Critical Distinction: Efficacy vs. Reflux Trade-off
What POEM Does Well:
- Equivalent or superior symptom relief compared to LHM, particularly for type III achalasia
- Shorter operative time (approximately 36 minutes less) 3
- Shorter hospital stay (0.7 days less) 3
- No external incisions
- Comparable complication rates to LHM 3
The Major Concern—GERD:
Post-POEM reflux is the primary limitation preventing POEM from being universally considered the gold standard. The evidence shows:
- 41-65% develop esophagitis after POEM 2
- 41-56% have abnormal acid exposure on objective testing 2
- One-quarter of patients are asymptomatic despite pathologic reflux 2
- Meta-analysis demonstrates 2.57 times higher odds of esophagitis with POEM compared to LHM (when outlier studies excluded) 3
- 1.72 times higher odds of requiring long-term PPI therapy 3
This is clinically significant because LHM includes a fundoplication (anti-reflux wrap), while standard POEM does not.
Evidence-Based Treatment Algorithm
For Type III (Spastic) Achalasia:
Choose POEM if available at a high-volume center 1
- The ability to perform longer myotomy provides superior outcomes
- Accept the trade-off of higher reflux risk with mandatory PPI therapy
For Type I and II Achalasia:
Either POEM or LHM are acceptable first-line options 1
Decision factors:
- Choose LHM if: Patient prioritizes minimizing reflux risk, prefers definitive anti-reflux protection with fundoplication, or POEM expertise unavailable
- Choose POEM if: High-volume center available, patient accepts indefinite PPI therapy, patient prioritizes avoiding external incisions
Mandatory Post-POEM Management:
- Immediate pharmacologic acid suppression with PPI therapy 2
- Objective reflux evaluation at 6-12 months with pH monitoring and/or endoscopy 2
- Do not rely on symptoms alone—25% with pathologic reflux are asymptomatic
- Long-term PPI therapy in most patients 2
- Surveillance endoscopy should be considered given the 4.6-fold increased esophageal cancer risk in achalasia patients 2
Critical Pitfalls to Avoid
Do not perform POEM without:
- Adequate operator experience (minimum 20-40 prior cases) 1
- Commitment to objective post-procedure reflux assessment 2
- Patient counseling about indefinite PPI therapy 1
Do not assume symptom-free means reflux-free after POEM—objective testing is essential 2
For Failed Initial Myotomy
POEM is superior to pneumatic dilation for salvage therapy after failed LHM or POEM, with 62% vs 27% success rates in randomized trial 2. However, this represents a minority of cases (10-15% experience treatment failure).
The Bottom Line
While recent research articles 4, 5 argue POEM is "the new gold standard," the authoritative AGA guidelines 2, 1 more appropriately position it as comparable to LHM, not superior across all scenarios. The higher reflux burden with POEM is a real quality-of-life consideration that prevents it from being universally superior. LHM with fundoplication remains the gold standard when reflux prevention is prioritized; POEM is the preferred option for type III achalasia and when minimally invasive endoscopic approach is prioritized with acceptance of higher reflux risk.